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Purpose: Urocanic acid (UCA) is a major ultraviolet (UV)-absorbing endogenous chromophore in the epidermis and is
also an efficacious immunosuppressant. The anti-inflammatory and cytoprotective effects of cis-UCA were studied in
ocular surface cell cultures exposed to UV-B irradiation.
Methods: Human corneal epithelial cells (HCE-2) and human conjunctival epithelial cells (HCECs) were incubated with
10, 100, 1,000, and 5,000 μg/ml cis-UCA with and without a single UV-B irradiation dose. The concentrations of
IL-1β, IL-6, IL-8, and TNF-α in the culture medium and caspase-3 activity in the cell extract sampled were measured by
enzyme-linked  immunosorbent  assay  (ELISA).  Cell  viability  was  measured  by  the  colorimetric  MTT  (3-(4,5-
dimethyldiazol- 2-yl)-2,5-diphenyltetrazolium bromide) assay.
Results: UV-B irradiation multiplied interleukin IL-6 and IL-8 secretion levels in HCE-2 cells and HCECs as analyzed
with ELISA. Cell viability as measured by the MTT assay declined by 30%–50% in HCE-2 cells and by 20%–40% in
HCECs after UV-B irradiation. Moreover, UV-B increased caspase-3 activity in both cell types as analyzed with ELISA.
Treatment with 100 μg/ml cis-UCA completely suppressed IL-6 and IL-8 secretion, decreased caspase-3 activity, and
improved cell viability against UV-B irradiation. No significant effects on IL-6 or IL-8 secretion, caspase-3 activity, or
viability  of  the  non-irradiated  cells  were  observed  with  100  μg/ml  cis-UCA  in  both  cell  types.  The  5,000  μg/ml
concentration was toxic.
Conclusions: These findings indicate that cis-UCA may represent a promising anti-inflammatory and cytoprotective
treatment option to suppress UV-B-induced inflammation and cellular damage in human corneal and conjunctival
epithelial cells.
Urocanic  acid  (UCA)  is  a  major  ultraviolet  (UV)-
absorbing  chromophore  in  the  epidermis,  and  it  has  been
proposed to function as a regulator of UV-induced damage in
photoimmunology [1]. The cis-UCA, formed from trans-UCA
upon  UV-B  exposure,  has  been  implicated  in  the  down-
regulation of hypersensitivity reactions [2,3] in the actions of
epidermal  antigen-presenting  cells  [4,5],  the  activation  of
neutrophils  [6,7],  and  the  prolonged  survival  of  organ
transplants [8], but the mechanisms of action still remain to
be resolved.
Ocular surface cells including corneal and conjunctival
cells  are  frequently  exposed  to  UV  radiation,  which  may
evoke epithelial damage, cell death, and inflammation [9,10].
Photokeratoconjunctivitis,  pinguecula,  pterygium,  nodular
band keratopathies, and epidermoid carcinoma are believed
to be the result of exposure to intense UV radiation of the
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ocular  surface  [11].  The  dry  eye  syndrome  is  the  most
common reason for ocular surface inflammation [12,13]. Dry
eye is associated with irritation of the ocular surface and
increased  risk  of  secondary  infections  [14].  In  the
multifactorial dry eye syndrome, there appears to be increased
production  of  proinflammatory  cytokines  such  as
interleukin-1  (IL-1),  interleukin-6  (IL-6),  interleukin-8
(IL-8), tumor necrosis factor-alpha (TNF-α), and proteolytic
enzymes.  These  cytokines  are  released  not  only  from  the
ocular surface and glandular epithelial cells but also from the
infiltrating inflammatory cells [15-19]. In this study, we have
investigated the role of cis-UCA in IL-1β, IL-6, IL-8, and
TNF-α immune response and cytotoxicity that are important
factors of inflammatory reactions in ocular cell types. We
show that cis-UCA suppresses UV-B-induced inflammation
and  cellular  damage  in  human  corneal  and  conjunctival
epithelial cells.
METHODS
Cell culture: Human corneal epithelial cells (HCE-2) and
human conjunctival epithelial cells (HCECs) were obtained
from American Type Culture Collection (Manassas, VA). The
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1799HCE-2 cells were cultured in Keratinocyte-SFM medium with
supplements (25 mg bovine pituitary extract and 2.5 µg human
recombinant  epidermal  growth  factor;  Gibco  Invitrogen,
Paisley, UK) including 10% fetal bovine serum (Hyclone,
Logan, UT), 100 U/ml penicillin, 100 µg/ml streptomycin
(Gibco Invitrogen), and 0.005 mg/ml insulin (Sigma-Aldrich,
St. Louis, MO). HCECs were cultured in Medium 199 (Gibco
Invitrogen)  supplemented  with  serum  and  antibiotics  as
described above. Confluent cultures of both cell lines were
treated with concentrations of 10, 100, 1,000, and 5,000 µg/
ml cis-UCA (BioCis Pharma, Turku, Finland) and exposed to
a UV-B irradiation dose of 153 mJ/cm2 (four TL 20W/12
tubes, Philips, Eindhoven, The Netherlands) in 12 well plates.
The irradiation was performed at room temperature for 1 min
using a source-to-target distance of 30 cm.
Enzyme-linked immunosorbent assay: The concentrations of
IL-1β, IL-6, IL-8, and TNF-α in the culture medium and
caspase-3 activity in the cell extract sampled at 24 h, 48 h, or
72 h were measured by enzyme-linked immunosorbent assay
(ELISA) using OptEIA™ sets from BD PharMingen (San
Diego, CA) according to the manufacturer's instructions.
MTT assay: Cell viability was assessed at 24 h, 48 h, or 72 h
after  the  start  of  the  treatments  by  the  3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl  tetrazolium  bromide
(MTT) test (Sigma-Aldrich) in 12 well plates. Briefly, 25 μl
of MTT solution (10 mg/ml in PBS) was added to 500 µl of
culture  medium  and  incubated  for  1.5  h  at  37  °C.  Then,
525  μl  of  MTT  lysis  buffer  (20%  SDS,  50%
dimethylformamide, pH 4.7) was added to the wells to induce
cellular lysis. The colorimetric assay is based on the ability of
Figure 1. Effect of cis-UCA on IL-6 secretion. The HCE-2 cells
(A) and HCECs (B) were either untreated (C) or exposed to different
concentrations of cis-UCA for 24, 48, or 72 h. For statistical analysis,
cis-UCA treated samples were compared with C samples. An asterisk
indicates p<0.05, and a double asterisk denotes p<0.001 (n=6 dishes).
viable  cells  to  metabolize  MTT.  The  absorbance  was
measured  at  550  nm  in  a  microplate  reader  (Bio-Rad
Laboratories, Hercules, CA).
HPLC analysis: Culture medium samples taken at the end of
the experiment were assayed for cis- and trans-UCA. Proteins
in the 200 μl medium samples were precipitated with 400 µl
of trichloroacetic acid on ice for 10 min, centrifuged (12,800×
g, 10 min, 4 °C), and analyzed with HPLC using the Agilent
1100 UV detection system (Agilent Technologies, Santa Clara
CA) at 268 nm.
Statistical analysis: The statistical significance was analyzed
with SPSS for Windows software (v. 11.5; SPSS, Chicago,
IL) using Mann–Whitney U-test. p-values below 0.05 were
considered significant.
RESULTS
In non-irradiated cells, the 10 and 100 µg/ml concentrations
of cis-UCA had only a negligible effect on IL-6 production
while treatment with 1,000 µg/ml of cis-UCA evoked a mild
but significant elevation on IL-6 levels in both cell types. A
major decrease in IL-6 secretion was observed with 5,000 µg/
ml cis-UCA in all time points (Figure 1A,B). Exposure of the
HCE-2  cells  and  HCECs  to  UV-B  irradiation  induced  a
maximum sevenfold to ninefold increase and twofold increase
in the measured IL-6 concentrations, respectively. Treatment
of both cell lines with cis-UCA at all studied concentrations
significantly  decreased  the  UV-B-induced  IL-6  secretion
(Figure  2A,B).  The  100  µg/ml  concentration  of  cis-UCA
completely  restored  the  UV-B-induced  increase  in  IL-6
secretion back to the level detected in the non-irradiated cells
after the 24-, 48-, and 72-h follow-up. IL-1β could not be
detected in the control, cis-UCA-treated, or UV-B-irradiated
cells (data not shown).
Analysis of cell viability by the MTT assay revealed no
significant effect in response to 10 and 100 µg/ml cis-UCA in
the non-irradiated cells during the 24-, 48-, and 72-h follow-
up (Figure 3A,B). The 1,000 µg/ml concentration evoked a
slight  decrease  in  viability  in  the  HCE-2  cells  but  not  in
HCECs while exposure to 5,000 µg/ml cis-UCA caused a
clear reduction of MTT metabolism, evidence of increased
cytotoxicity in both cell types (Figure 3A,B). Exposure of the
cells  to  UV-B  decreased  the  viability  by  20%–50%  .
Interestingly,  the  100  µg/ml  concentrations  of  cis-UCA
restored the metabolic activity of the UV-irradiated cells to
the level of the non-irradiated cells in all time points (Figure
3A,B), pointing to the presence of a cytoprotective effect of
cis-UCA.
In the functional assays with HCE-2 cells and HCECs,
cis-UCA was present in the culture medium at the time of
irradiation and during the 24 h recovery period. Since the UCA
isomers  absorb  in  the  UV-B  wavelength  region  and  can
photoisomerize to each other (Figure 4A), it was investigated
whether photoisomerization had actually taken place in the
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1800experiments and could have affected the biological response.
A total of 16 medium samples from the assays were subjected
to HPLC analysis. The mean concentration of cis-UCA in the
cis-UCA-treated (100 µg/ml) medium samples was 87.8 µg/
ml (HCE-2) and 90.5 µg/ml (HCEC). The rest of the cis-UCA
had apparently been taken up by the cells. Trans-UCA was
detected in the non-irradiated samples at levels of 6.4% in
HCE-2 cells and 4.0% in HCECs from the total UCA (Figure
4B,C). After exposure to UV-B irradiation as shown above,
the net photoisomerization to trans-UCA was 13.1% in HCE-2
cells and 11.1% in HCECs. The cis-UCA concentrations were
72.3  μg/ml  in  HCE-2  cells  and  74.9  μg/ml  in  HCECs  in
response to UV-B (Figure 4). This level of photoisomerization
was estimated to have a negligible effect on cytokine secretion
and viability.
Figure  2.  Effect  of  cis-UCA  on  UV-irradiation-induced  IL-6
secretion. The HCE-2 cells (A) and HCECs (B) were non-irradiated
(C) or UV-irradiated (UV; lower panels), or exposed to different
concentrations of cis-UCA or UV irradiated and treated with cis-
UCA for 24, 48, or 72 h (upper panels). For statistical analysis, cis-
UCA+UV samples were compared with UV samples. An asterisk
indicates p<0.05, and a double asterisk denotes p<0.001 (n=6 dishes).
Next,  the  effect  of  phenol  red  on  IL-6  secretion  in
response to UV-B irradiation of the cells was examined. The
cells were irradiated in a colorless buffer solution or in a
normal culture medium prior to change of medium without or
with 100 μg/ml cis-UCA and were then followed for 24 h. As
shown in Figure 5, no significant differences between the
effects of the phenol red-containing medium and the colorless
solution on IL-6 secretion can be seen in ocular surface cells.
The  100  µg/ml  concentration  of  cis-UCA  completely
restored the UV-B-induced increase in IL-6 secretion (Figure
2). Therefore, we wanted to analyze IL-8 and TNF-α secretion
in  similar  conditions.  Exposure  of  the  HCE-2  cells  and
HCECs to UV-B irradiation induced a four- to fivefold and
threefold  increase  in  the  measured  IL-8  concentrations,
respectively. Treatment of both cell lines with 100 µg/ml cis-
UCA  significantly  decreased  the  UV-B-induced  IL-8
secretion (Figure 6A,B). TNF-α could not be detected in the
Figure 3. Effects of cis-UCA and UV irradiation on viability. The
non-irradiated (C) and UV-irradiated (UV) HCE-2 cells (A) and
HCECs (B) were exposed to different concentrations of cis-UCA for
up to 72 h. For statistical analysis, cis-UCA samples and cis-UCA
+UV samples were compared with C samples. An asterisk indicates
p<0.05, and a double asterisk denotes p<0.001 (n=6 dishes).
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1801control, cis-UCA-treated, or UV-B-irradiated cells (data not
shown).
Since the 100 µg/ml concentration of cis-UCA restored
the metabolic activity of the UV-irradiated cells (Figure 3),
we finally analyzed caspase-3 activity. Treatment of both cell
lines with 100 µg/ml cis-UCA significantly decreased the UV-
B-induced caspase-3 activity after 24 h follow-up (Figure
7A,B). This is in line with the MTT assay results (Figure 3)
and reveals anti-apoptotic effects of cis-UCA in the HCE-2
cells and HCECs.
Figure 4. Photoisomerization of UCA. UV excitation of one isomer
leads to the formation of the other isomer (A). The concentrations of
UCA isomers is measured in the cell culture medium of HCE-2 cells
(B) and HCECs (C) treated with 100 µg/ml cis-UCA for 24 h with
or without UV irradiation.
DISCUSSION
Our results demonstrate that cis-UCA possesses both anti-
Figure  5.  UV  absorption  effect  of  the  culture  medium  on  IL-6
secretion. The HCE-2 cells (A) and HCECs (B) were irradiated in a
colorless buffer solution or in a normal culture medium prior to
change of medium without or with 100 μg/ml cis-UCA and were then
followed for 24 h. An asterisk indicates p<0.05, and a double asterisk
denotes  p<0.001  (n=6  dishes).  Abbreviations:  C,  control;  m,
medium; PBS, phosphate buffered saline; UCA, urocanic acid; UV,
ultraviolet.
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1802inflammatory and cytoprotective effects against an external
stress,  in  this  case  UV-B  irradiation,  in  human  corneal
(HCE-2)  and  conjunctival  epithelial  (HCEC)  cells.  Many
previous reports have described cell type dependent responses
of cytokine expression after treatment with cis-UCA. Cis-
UCA at concentrations of 10–100 µg/ml has been documented
to  increase  IL-6,  IL-8,  and  TNF-α  secretion  in  human
keratinocytes [20]. One study revealed an increased IL-10
production  in  activated  CD4+  T  cells  [21]  while  another
indicated that cis-UCA could inhibit secretion of IL-10 in T
lymphocytes [22]. It has been suggested that cis-UCA may
stimulate the cytokine cascade by induction of prostaglandin-
E2 (PGE2) in keratinocytes [20,23] while in peripheral blood
monocytes, it attenuated the PGE2- induced release of TNF-
α [24]. However, there are findings that low doses of cis-UCA
have  not  had  an  effect  on  IL-1  or  IL-6  production  in
monocytes [24,25]. Similarly, IL-1 could not be induced by
10–100  µg/ml  cis-UCA  in  human  keratinocytes  [20].  In
agreement with these reports, our results indicate that low
doses of cis-UCA did not affect IL-1β, IL-6, IL-8, or TNF-α
secretion in human corneal and conjunctival cells. The data
also show that 100 µg/ml cis-UCA significantly decreased the
UV-B-induced secretion of IL-6 and IL-8 in these cells. It is
of interest to note that the 1,000 µg/ml concentration of cis-
UCA increased the IL-6 levels in the non-irradiated cells.
However,  our  findings  are  evidence  of  clear  anti-
inflammatory activity of cis-UCA on UV-irradiated ocular
surface cell types.
It is well known that UV radiation can cause cell damage
and even the death of ocular surface cells [9,26]. In human
and  animal  skin,  UCA  is  the  major  UV-absorbing
chromophore, but how it causes this effect is still far from
clear.  According  to  a  recent  view,  cis-UCA  may  induce
immune  suppression  via  cells  that  express  the  5-
hydroxytryptamine  (serotonin)  receptor  2A  (5-HT2A)
receptor [27]. In addition to the limited signaling data, only a
few studies have determined the toxicity of cis-UCA in cell
cultures [28]. Our findings demonstrated good tolerability of
HCE-2 cells and HCECs to low concentrations (10–1,000 µg/
ml) of cis-UCA whereas the highest concentration studied
(5,000 µg/ml) was clearly toxic. For comparison, a cis-UCA
concentration  of  3,000  µg/ml  in  a  mildly  acidic  medium
decreased the mitochondrial metabolic capacity by about 90%
in a bladder carcinoma cell line [29]. With respect to both
toxicity and biological effects, the optimal concentration in
the present investigation seemed to be 100 µg/ml cis-UCA
since this was able to prevent as well as to fully restore both
of the measured UV-B-induced changes, i.e., the decrease in
metabolic activity and the increase in IL-6 secretion, back to
the level of the non-irradiated control cells. Thus, 100 µg/ml
cis-UCA was optimally anti-inflammatory and cytoprotective
against  cellular  damage  caused  by  UV-B  radiation  in  the
present  experimental  setting.  It  should  be  noted  that  the
decrease in mitochondrial metabolic activity measured by the
MTT assay after UV-B irradiation may not be caused by the
irradiation  only  because  the  UV-B  dose  induced  IL-6
secretion at the nanomolar level, which can directly decrease
MTT  metabolism  [30].  The  UV-B  irradiation  induced
caspase-3 activity in both cell types, which revealed apoptotic
cell death and supported the MTT assay data. Treatment with
100  µg/ml  cis-UCA  also  effectively  prevented  caspase-3
activity  in  the  UV-B  treated  cells.  Since  elevated  IL-1β
Figure  6.  Effect  of  cis-UCA  on  UV-
irradiation-induced IL-8 secretion. The
HCE-2 cells (A) and HCECs (B) were
non-irradiated (C), UV-irradiated (UV),
treated  with  100  mg/ml  cis-UCA  (c-
UCA),  or  UV-irradiated  and  treated
with cis-UCA (100 mg/ml c-UCA+UV)
for  24,  48,  or  72  h.  Statistical
significance  is  shown  by  an  asterisk
(p<0.05) or a double asterisk (p<0.001;
n=6  dishes).  Compared  samples  are
shown by the horizontal lines.
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1803secretion levels were not observed in any of the treatments,
inflammasomes and caspase-1 are obviously not involved in
the UV-B or cis-UCA responses. Caspase-1 is the principal
caspase  found  in  human  inflammasomes  that  cleave  the
precursors of pro-inflammatory cytokines such as IL-1β to
mature and active cytokines, which are subsequently secreted
from cells [31].
The UV-B irradiation dose used in the study evoked a low
level of photoisomerization from cis- UCA to trans-UCA.
This may have caused some effect on IL-6 secretion, although
we  consider  it  unlikely.  The  presence  of  very  low
concentrations (<4 µg/ml) of trans-UCA in the non-irradiated
samples  treated  with  100  µg/ml  cis-UCA  may  reflect
unintentional  exposure  to  laboratory  lighting.  In  previous
reported  studies  with  cis-UCA,  analyses  of  the  actual
concentrations of the isomers have rarely been conducted, and
often various mixtures of the cis and trans isomers have been
used. It is possible that the very highest UCA concentrations
(1,000  and  5,000  µg/ml)  may  have  partially  blocked  the
transmission of the UV-B photons in the culture medium,
thereby  preventing  the  full  cell-irritating  action  of  the
irradiation. A smaller absorbing effect may have been caused
by the medium ingredients, although no differential effect on
IL-6 levels could be observed when using a bright buffer
solution instead of the phenol red-containing colored medium.
The prolonged exposure of the ocular surface to UV light can
cause  cellular  damage.  There  are  different  stages  of
inflammation in the ocular surface due to alterations in the
volume  and  composition  of  tear  fluid  [15,16,19,32,33].
Current  clinical  therapy  for  ocular  surface  inflammation
consists of anti-inflammatory agents that do not offer any
protection against UV radiation-induced damage [34]. Our in
vitro findings suggest that cis-UCA may provide a safe and
effective  anti-inflammatory  and  cytoprotective  treatment
option  against  UV  radiation-induced  inflammation  on  the
ocular surface.
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